Home > Riviste > Minerva Anestesiologica > Fascicoli precedenti > Articles online first > Minerva Anestesiologica 2018 Jan 16

ULTIMO FASCICOLO
 

ARTICLE TOOLS

Publication history
Estratti
Per citare questo articolo

MINERVA ANESTESIOLOGICA

Rivista di Anestesia, Rianimazione, Terapia Antalgica e Terapia Intensiva


Official Journal of the Italian Society of Anesthesiology, Analgesia, Resuscitation and Intensive Care
Indexed/Abstracted in: Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 2,623


eTOC

 

Minerva Anestesiologica 2018 Jan 16

DOI: 10.23736/S0375-9393.18.12287-5

Copyright © 2018 EDIZIONI MINERVA MEDICA

lingua: Inglese

The role of cannabinoids in pain control: the good, the bad, and the ugly

Joseph V. PERGOLIZZI Jr. 1, Jo Ann LEQUANG 1, Robert TAYLOR Jr. 1, Robert B. RAFFA 1, Daniel COLUCCI 2, on behalf of the NEMA Research Group

1 NEMA Research, Inc., Naples, Italy; 2 Department of Bioengineering, Northeastern University, Boston, MA, USA


PDF  


Cannabinoids appear to possess many potential medical uses, which may extend to pain control. A narrative review of the literature has found a variety of studies testing botanical and synthetic cannabinoids in different pain syndromes (acute pain, cancer pain, chronic noncancer pain, fibromyalgia pain, migraine, neuropathic pain, visceral pain, and others). Results from these studies are mixed; cannabinoids appear to be most effective in controlling neuropathic pain, allodynia, medication-rebound headache, and chronic noncancer pain, but do not seem to offer any advantage over nonopioid analgesics for acute pain. Cannabinoids seem to work no better than placebo for visceral pain and conferred only modest analgesic effect in cancer pain. Cannabinoids do many good things-they appear to be effective in treating certain types of pain without the issues of tolerance associated with opioids. Negatively, marijuana currently has a very murky legal status all over the world-laws regulating its use are inconsistent and in flux. Thus, both patients and prescribers may be unsure about whether or not it is an appropriate form of pain control. Cannabinoid-based analgesia has been linked to potential memory deficits and cognitive impairment. A great deal more remains to be elucidated about cannabinoids which may emerge to play an important role in the treatment of neuropathic and possibly other painful conditions. There remains a great deal more to learn about the role of cannabinoids in pain management.


KEY WORDS: Cannabinoid - THC - Marijuana - Chronic pain - Analgesia

inizio pagina

Publication History

Article first published online: January 16, 2018
Manuscript accepted: January 10, 2018
Manuscript revised: November 15, 2017
Manuscript received: July 5, 2017

Per citare questo articolo

Pergolizzi JV Jr., Lequang JA, Taylor R Jr., Raffa RB, Colucci D; the NEMA Research Group. The role of cannabinoids in pain control: the good, the bad, and the ugly. Minerva Anestesiol 2018 Jan 16. DOI: 10.23736/S0375-9393.18.12287-5

the NEMA Research Group

Corresponding author e-mail

joann@leqmedical.com